ool of Medicine, 317  E. 34th Street, Fourth Floor, New York, N.Y. 10016, United States, Tel.: +1  212 981 7230, Fax: +1 212 726 7452, E-mail: greenj09@med.nyu.edu</p>

<p>Background:  When maximal viral suppression is the goal of  HAART, drug regimens become complex and more toxic. The study  objective was to seek differences in clinical course between  patients whose HIV is maximally, and sub-maximally suppressed. Methods:  A practice with 600 HIV patients has been part of a  large observational database.